New Mountain Capital-backed Aceto completed the acquisition of Syntor Fine Chemicals.

New Mountain Capital-backed Aceto, a virtual manufacturer of specialty materials for life sciences, nutrition, agricultural, and advanced technology end markets, completed the acquisition of Syntor Fine Chemicals, an asset-light manufacturer of fine chemicals for pharmaceutical and other life sciences end markets. Financial terms were not disclosed. “The acquisition of Syntor is an important step in Aceto’s strategic growth plan. Syntor’s synthesis and formulation capabilities enhance Aceto’s existing services and expand our value-added offerings in life sciences materials. With the addition of Syntor’s technical team, we can provide greater product customization in addition to supplying our current offering of high quality, specialty materials," Gilles Cottier, Aceto Chief Executive Officer.